These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33621144)

  • 21. Precision genome editing in the eye.
    Suh S; Choi EH; Raguram A; Liu DR; Palczewski K
    Proc Natl Acad Sci U S A; 2022 Sep; 119(39):e2210104119. PubMed ID: 36122230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR/Cas9 genome surgery for retinal diseases.
    Xu CL; Park KS; Tsang SH
    Drug Discov Today Technol; 2018 Aug; 28():23-32. PubMed ID: 30205877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome engineering in ophthalmology: Application of CRISPR/Cas to the treatment of eye disease.
    Hung SSC; McCaughey T; Swann O; Pébay A; Hewitt AW
    Prog Retin Eye Res; 2016 Jul; 53():1-20. PubMed ID: 27181583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR-Cas9 and Its Therapeutic Applications for Retinal Diseases.
    Lin WV; Stout JT; Weng CY
    Int Ophthalmol Clin; 2019; 59(1):3-13. PubMed ID: 30585915
    [No Abstract]   [Full Text] [Related]  

  • 25. Gene editing in dermatology: Harnessing CRISPR for the treatment of cutaneous disease.
    Baker C; Hayden MS
    F1000Res; 2020; 9():281. PubMed ID: 32528662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
    Li C; Brant E; Budak H; Zhang B
    J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR-Cas9: A cornerstone for the evolution of precision medicine.
    Razzouk S
    Ann Hum Genet; 2018 Nov; 82(6):331-357. PubMed ID: 30014471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome Editing in Retinal Diseases using CRISPR Technology.
    Yiu G
    Ophthalmol Retina; 2018 Jan; 2(1):1-3. PubMed ID: 31047294
    [No Abstract]   [Full Text] [Related]  

  • 29. [Current researches and prospects of human induced pluripotent stem cells and gene editing technology of CRISPR/Cas9 in inherited ocular diseases].
    Fan F; Wu JH; Luo Y
    Zhonghua Yan Ke Za Zhi; 2021 Sep; 57(9):712-716. PubMed ID: 34865411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Precision Medicine Trials in Retinal Degenerations.
    Levi SR; Ryu J; Liu PK; Tsang SH
    Annu Rev Vis Sci; 2021 Sep; 7():851-865. PubMed ID: 34524878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene and epigenetic editing in the treatment of primary ciliopathies.
    Molinari E; Sayer JA
    Prog Mol Biol Transl Sci; 2021; 182():353-401. PubMed ID: 34175048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Success in Sight for Gene Editing.
    Bainbridge JWB
    N Engl J Med; 2024 Jun; 390(21):2025-2027. PubMed ID: 38838317
    [No Abstract]   [Full Text] [Related]  

  • 33. Applications of genome editing tools in precision medicine research.
    Li S; Yang YY; Qiu Y; Chen Y; Xu LW; Ding QR
    Yi Chuan; 2017 Mar; 39(3):177-188. PubMed ID: 28420614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basic Principles and Clinical Applications of CRISPR-Based Genome Editing.
    Lim JM; Kim HH
    Yonsei Med J; 2022 Feb; 63(2):105-113. PubMed ID: 35083895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocular delivery of CRISPR/Cas genome editing components for treatment of eye diseases.
    Yu W; Wu Z
    Adv Drug Deliv Rev; 2021 Jan; 168():181-195. PubMed ID: 32603815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deconstructing cancer with precision genome editing.
    Johnson GA; Gould SI; Sánchez-Rivera FJ
    Biochem Soc Trans; 2024 Apr; 52(2):803-819. PubMed ID: 38629716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developing Non-Human Primate Models of Inherited Retinal Diseases.
    Seah I; Goh D; Chan HW; Su X
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR in personalized medicine: Industry perspectives in gene editing.
    Hong A
    Semin Perinatol; 2018 Dec; 42(8):501-507. PubMed ID: 30376985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR/Cas9-mediated genome editing: From basic research to translational medicine.
    Jacinto FV; Link W; Ferreira BI
    J Cell Mol Med; 2020 Apr; 24(7):3766-3778. PubMed ID: 32096600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.